Transfusion adverse events in a tertiary hospital from 2016 to 2022: a retrospective analysis
10.13303/j.cjbt.issn.1004-549x.2023.07.011
- VernacularTitle:某三甲综合性医院2016—2022年输血不良事件回顾性分析
- Author:
Yachun SUN
1
;
Leiping WANG
1
;
Guihua DENG
1
;
Xinyan LONG
1
;
Shunling YUAN
1
;
Qingbao MENG
1
Author Information
1. Shenzhen People's Hospital, Shenzhen 518020, China
- Publication Type:Journal Article
- Keywords:
haemovigilance;
transfusion adverse events;
human factors;
auality control
- From:
Chinese Journal of Blood Transfusion
2023;36(7):601-604
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To strengthen the management of transfusion adverse events, so as to reduce the occurrence of medical damage and accidents, and guarantee the safety of blood transfusion. 【Methods】 The adverse events of blood transfusion reported in our hospital from July 2016 to December 2022 were collected, the reasons were tracked, and continuous improvements were made. 【Results】 From 2016 to 2022, a total of 315 transfusion adverse events were reported, including 233(73.97%, 233/315) cases of transfusion reactions and 82(26.03%, 82/315) transfusion adverse events. There were 271 328 transfusion cases in the same period, and the incidence of transfusion reactions was 0.858 7‰(233/271 328). The number of transfusion application was 129 887, and the incidence of transfusion adverse event is 0.631 3‰(82/129 887). Sixty-eigtht(82.93%, 68/82) cases of transfusion adverse events were caused by human factors, while the other 14(17.07%, 14/82) cases were non-human factors. According to the linear regression analysis, we have concluded that the year is a significant indicator for transfusion reaction rates (P<0.05), but not for transfusion adverse event rates (P>0.05). 【Conclusion】 Strengthening the management of reporting adverse events in clinical blood transfusion, monitoring the incidence, analyzing and improving different types of adverse events by management tools can reduce the medical risks of blood transfusion and help to guarantee the safety of clinical blood transfusion.
